临床试验
Explore how we turn our research into reality.\r\n"}}" id="text-8d81951062" class="cmp-text">
探索我们如何把我们的研究变成现实。
关于临床试验
A critical component of developing medicines is clinical research. This involves conducting clinical trials in humans to evaluate the safety and efficacy of investigational medications. Sometimes these studies include healthy volunteers but most of the studies are conducted in patients with the diseases we are studying.
\r\n
\r\nLocal authorities, such as the European Medicines Agency (EMA), the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan, the U.S. Food and Drug Administration (FDA), as well as those in many other countries, use the data gathered in these trials to determine whether or not to approve the medication for use in their countries. To ensure these studies are conducted to the highest standards of protection for individuals who participate in the studies, AbbVie strictly follows important rules governing clinical research. These include the World Medical Association’s (WMA) Declaration of Helsinki, the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) and all applicable local rules and regulatory requirements.\r\n"}}" id="text-e700d4516f" class="cmp-text">
\r\n
\r\nLocal authorities, such as the European Medicines Agency (EMA), the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan, the U.S. Food and Drug Administration (FDA), as well as those in many other countries, use the data gathered in these trials to determine whether or not to approve the medication for use in their countries. To ensure these studies are conducted to the highest standards of protection for individuals who participate in the studies, AbbVie strictly follows important rules governing clinical research. These include the World Medical Association’s (WMA) Declaration of Helsinki, the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) and all applicable local rules and regulatory requirements.\r\n"}}" id="text-e700d4516f" class="cmp-text">
发展中药物临床研究的一个关键组成部分。这包括进行人类临床试验来评估临床实验药物的安全性和有效性。有时,这些研究包括健康的志愿者,但大多数的研究是我们正在研究的疾病患者进行。
地方当局,如欧洲药品局(EMA),药品和医疗器械机构(PMDA)在日本,美国食品和药物管理局(FDA),以及在许多其他国家,在这些试验中使用收集的数据来决定是否批准该药物用于他们的国家。确保这些研究进行最高标准的保护个人参与研究,AbbVie严格遵循临床研究重要的规则。其中包括世界医学协会(WMA)赫尔辛基宣言、国际委员会统一技术要求药品对人类使用(我)和所有适用的当地规则和监管要求。
相关内容
Learn more about AbbVie clinical trials \r\n"}}" id="text-03fa6e230c" class="cmp-text">
了解更多关于AbbVie临床试验
我们不妥协的完整性的基础是我们的代码的商业行为。
We believe in the design of inclusive research programs that offer equitable access and enhanced trial experiences for both patient and physician.
\r\n
\r\nWe are committed to being both intentional and representative when it comes to the inclusion of diverse populations of investigator staff and patients in the disease areas we are studying.\r\n"}}" id="text-d6b186adbd" class="cmp-text">
\r\n
\r\nWe are committed to being both intentional and representative when it comes to the inclusion of diverse populations of investigator staff and patients in the disease areas we are studying.\r\n"}}" id="text-d6b186adbd" class="cmp-text">
我们相信包容的设计研究项目提供公平获得和增强审判经验对病人和医生。
我们致力成为故意和代表时的不同种群的侦探工作人员和病人在疾病领域,我们正在研究。
致力于良好的临床实践
Throughout the clinical trials process, patients remain our highest priority. Good Clinical Practice (GCP) is a global ethical and scientific quality standard for designing, conducting, recording and reporting clinical trials. Compliance with this standard provides public assurance that the rights, safety and well-being of trial subjects are protected, consistent with global ethical standards and regulatory requirements. Compliance also assures the credibility of the clinical data. AbbVie is committed to ensuring Good Clinical Practice is strictly adhered to within all AbbVie-sponsored clinical trials.\r\n"}}" id="text-db90c8fb8c" class="cmp-text">
在临床试验过程中,患者仍然是我们的最高优先级。良好的临床实践(GCP)是一个全球性的伦理和科学设计、质量标准进行,记录和报告临床试验。遵守这个标准提供公众保证权利、安全和幸福的受试者保护,符合全球道德标准和监管要求。合规也保证了临床数据的可信度。AbbVie致力于确保良好的临床实践中严格遵守所有AbbVie-sponsored临床试验。
加入我们的临床试验站点网络
AbbVie partners with leading scientific and medical professionals around the world to conduct clinical trials. We value the significant contributions that our scientific and medical professional partners make to our scientific innovation. AbbVie is committed to establishing collaborative partnerships to continuously grow our clinical trial site network.\r\n
To become a clinical trial investigator / investigative site on an AbbVie trial, submit your interest here: investigatorinquiry.abbvie.net.
\r\n"}}" id="text-0f5077d061" class="cmp-text">AbbVie伙伴与全球领先的科学和医学专业人员进行临床试验。我们珍视我们的科学和医学的重大贡献专业合作伙伴对我们的科学创新。AbbVie致力于建立合作伙伴关系,不断扩大我们的临床试验网络。
成为临床试验研究者/ AbbVie试验调查网站,提交你的兴趣:investigatorinquiry.abbvie.net。
研究者发起的研究(IIS)计划
The Investigator-Initiated Studies (IIS) Program provides an opportunity for academic and community-based physicians and researchers worldwide interested in conducting their own research to apply for research support. To learn about investigator-initiated studies, please visit this page.\r\n"}}" id="text-ec7a2b45db" class="cmp-text">
研究者发起的研究(IIS)计划提供了一个机会,全世界学术和社区医生和研究人员感兴趣的进行自己的研究申请研究支持。学习研究者发起的研究,请访问这个页面。
外部链接
Unless otherwise specified, all product names appearing in this internet site are trademarks owned by or licensed to AbbVie Inc., its subsidiaries or affiliates. No use of any AbbVie trademark, trade name, or trade dress in this site may be made without the prior written authorization of AbbVie Inc., except to identify the product or services of the company.\r\n
Copyright © 2023 AbbVie Inc. North Chicago, Illinois, U.S.A.
\r\n"}}" id="text-672b95c6da" class="cmp-text">除非另有规定,所有产品名称出现在本网站商标或许可AbbVie Inc .旗下的子公司或分支机构。没有使用任何AbbVie商标,商号,或贸易服装在这个网站可能没有AbbVie Inc .的事先书面授权,除了确定公司的产品或服务。
版权©2023 AbbVie Inc .北芝加哥,伊利诺斯州,美国
